Nicollaq Vozhilla
Overview
Explore the profile of Nicollaq Vozhilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
256
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoo B, Gredler R, Vozhilla N, Su Z, Chen D, Forcier T, et al.
Proc Natl Acad Sci U S A
. 2009 Jul;
106(31):12938-43.
PMID: 19622726
Astrocyte elevated gene-1 (AEG-1) is overexpressed in >90% of human hepatocellular carcinoma (HCC) patients and plays a significant role in mediating aggressive progression of HCC. AEG-1 is known to augment...
2.
Park M, Walker T, Martin A, Allegood J, Vozhilla N, Emdad L, et al.
Mol Cancer Ther
. 2009 May;
8(5):1280-91.
PMID: 19417161
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) is a novel cytokine displaying selective apoptosis-inducing activity in transformed cells without harming normal cells. The present studies focused on clarifying the mechanism(s) by which...
3.
Yacoub A, Park M, Gupta P, Rahmani M, Zhang G, Hamed H, et al.
Mol Cancer Ther
. 2008 Feb;
7(2):297-313.
PMID: 18281515
Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) is a novel cytokine displaying selective apoptosis-inducing activity in transformed cells without harming normal cells. The present studies focused on defining the mechanism(s) by which a...
4.
Lebedeva I, Emdad L, Su Z, Gupta P, Sauane M, Sarkar D, et al.
Int J Oncol
. 2007 Oct;
31(5):985-1007.
PMID: 17912425
Subtraction hybridization applied to a 'differentiation therapy' model of cancer employing human melanoma cells resulted in the cloning of melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Initial studies confirm an inverse correlation...
5.
Sarkar D, Lebedeva I, Su Z, Park E, Chatman L, Vozhilla N, et al.
Cancer Res
. 2007 Jun;
67(11):5434-42.
PMID: 17545625
Terminal prostate cancer is refractory to conventional anticancer treatments because of frequent overexpression of antiapoptotic proteins Bcl-2 and/or Bcl-x(L). Adenovirus-mediated delivery of melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), a secreted cytokine...